Vincent J. Picozzi

Dr. Vincent J Picozzi, MD MMM is Director for the Pancreas Center of Excellence, Virginia Mason Digestive Disease and Cancer Institutes, Virginia Mason Medical Center. A summa cum laude, Phi Beta Kappa graduate from Yale University, Dr. Picozzi obtained his MD degree from Stanford University, did his internship and residency at Harvard University (Brigham and Women’s Hospital), and fellowships in hematology and oncology again at Stanford. He also holds a Master’s degree in Medical Management, Delta Omega, from Tulane University. Dr. Picozzi was an instructor in hematology and oncology at Stanford for two years before joining Virginia Mason, where he has been for the past 31 years. Dr. Picozzi has one of the largest pancreaticobiliary oncology practices in the United States. He has received numerous accolades as a clinician, including designation as one of Seattle’s Best Doctors and one of America’s Top Cancer Doctors for the last eleven consecutive years (2008-2018). He also directs an active, comprehensive clinical and translational research program in pancreaticobiliary cancer at Virginia Mason, and has published over 100 papers and abstracts. Dr. Picozzi is currently serving on the education committees for the GI Oncology Symposium and ASCO for non-colorectal cancers and served as Educational Chair for both in 2016. He has been a featured speaker at virtually every major clinical oncologic meeting in the United States, including ASCO (the American Society of Clinical Oncology), ASH (the American Society of Hematology), ASTRO (the American Society of Therapeutic Radiation Oncology), Digestive Diseases Week, AHPBA (The American HepatoPancreaticobiliary Association), ACOS (the American College of Surgeons), the Best of ASCO, the GI Oncology Symposium and the World Pancreas Symposium. Dr. Picozzi also has held a number of leadership positions with national and regional organizations, including ASCO, ASH, the American College of Surgeons Oncology Group (ACOSOG), the Pancreatic Cancer Action Network where he is a past chairman and current board member for the Scientific and Medical Advisory Board chairing Clinical Initiatives, the Pancreas Cancer Research Team (PCRT-Executive Committee), and the Providence Hospice of Seattle (Executive Board). He also has proudly served on the Executive Board of the Washington State Medical Oncology Society since its inception 25 years ago, twice serving as president. Recently, Dr. Picozzi was named national clinical chairman and co-principal investigator of the new Precision Promise Clinical Research Consortium sponsored by the Pancreatic Cancer Action Network.